Search Results for: Breakthrough Therapy

October 1, 2019October 1, 2019

Revolution in biomedicine using emerging of picomaterials: A breakthrough on the future of medical diagnosis and therapy.

Publication date: Sep 27, 2019 Biomedicine is inseparable part of medicine that play vital role in modern medical progress. Bioimaging, smart drug delivery, safe cancer therapy and personalized medicine are ... Read more

April 27, 2018April 27, 2018

Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.

Multiple Sclerosis Literature

Publication date: Apr 25, 2018 Relapsing-remitting multiple sclerosis (RRMS) requires efficient immunomodulatory treatment to reach “no evidence of disease activity” status at best. Alemtuzumab and fingolimod have proved to be ... Read more

March 20, 2018March 20, 2018

Breakthrough stem cell transplant therapy for Multiple Sclerosis announced at EBMT 2018

Multiple Sclerosis Media

Publication date: Mar 20, 2018 Richard Burt of Northwestern University, Chicago has been awarded the van Bekkum prize for his lead in a game changing, stem cell transplant therapy for ... Read more

December 4, 2019December 4, 2019

RightEye Vision System Receives Breakthrough Device Designation from U.S. FDA for Parkinson’s Disease Test

Parkinson's Disease News

Publication date: Dec 04, 2019 The FDA’s Breakthrough Device Program was designed to streamline the market clearance and approval process for certain medical devices that provide for more effective treatment ... Read more

December 1, 2019December 1, 2019

Engineered nano-immunopotentiators efficiently promote cancer immunotherapy for inhibiting and preventing lung metastasis of melanoma.

Melanoma Literature

Publication date: Dec 01, 2019 Malignant melanoma, one of the most aggressive types of cancer easily metastasizes, making it extremely difficult to treat and unresponsive to current therapies. Recent breakthroughs ... Read more

November 29, 2019November 29, 2019

Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy.

Melanoma Literature

Publication date: Oct 04, 2019 Nivolumab plus ipilimumab combined therapy is one of the promising drugs that enhance the anti- immune response in patients with advanced melanoma. Therefore, to increase ... Read more

November 29, 2019November 29, 2019

Combination checkpoint inhibitor therapy induces multiple immune major related adverse events in the treatment of vaginal melanoma: A cautionary case report.

Melanoma Literature

Publication date: Nov 01, 2019 Immune checkpoint inhibitors (ICI) eliminate cancer cells through release of inhibition of cytotoxic CD8+ lymphocytes. Potent systemic activation of immune cells provides unprecedented efficacy in ... Read more

November 28, 2019November 28, 2019

Neoadjuvant Immunotherapy with combined Ipilimumab and Nivolumab in Melanoma Patients with Primary or In-transit Disease.

Melanoma Literature

Publication date: Nov 26, 2019 The introduction of new therapeutic agents has revolutionized the treatment of metastatic melanoma. The approval of adjuvant anti-PD-1 monotherapy with nivolumab or pembrolizumab and dabrafenib ... Read more

November 25, 2019November 25, 2019

Anti-PD-1immunotherapy in advanced metastatic melanoma: State of the art and future challenges.

Melanoma Literature

Publication date: Nov 21, 2019 Immunotherapy with immune checkpoint inhibitors, such as anti-PD-1 drugs, is an area in increasing development for its efficacy and advantages in the treatment of advanced ... Read more

November 22, 2019November 22, 2019

Timing of Immunotherapy Discontinuation Remains Challenging in Melanoma

Melanoma Media

Publication date: Nov 19, 2019 Thomas Marron, MD, an assistant professor of medicine, hematology and medical oncology at Mount Sinai Hospital, discusses the rationale for investigating immunotherapy discontinuation in patients ... Read more